Cargando…

Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model

BACKGROUND: Myocardial injury is a frequent complication after cardiac surgery with cardiopulmonary bypass (CPB). This study aimed to test the hypothesis that melatonin could attenuate myocardial injury in a rat CPB model. METHODS: Eighteen male Sprague-Dawley rats were randomly divided into three g...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaolin, Hou, Jian, Huang, Suiqing, Feng, Kangni, Yue, Yuan, Li, Huayang, Huang, Shaojie, Liang, Mengya, Chen, Guangxian, Wu, Zhongkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053380/
https://www.ncbi.nlm.nih.gov/pubmed/33954056
http://dx.doi.org/10.7717/peerj.11264
_version_ 1783680110010826752
author Huang, Xiaolin
Hou, Jian
Huang, Suiqing
Feng, Kangni
Yue, Yuan
Li, Huayang
Huang, Shaojie
Liang, Mengya
Chen, Guangxian
Wu, Zhongkai
author_facet Huang, Xiaolin
Hou, Jian
Huang, Suiqing
Feng, Kangni
Yue, Yuan
Li, Huayang
Huang, Shaojie
Liang, Mengya
Chen, Guangxian
Wu, Zhongkai
author_sort Huang, Xiaolin
collection PubMed
description BACKGROUND: Myocardial injury is a frequent complication after cardiac surgery with cardiopulmonary bypass (CPB). This study aimed to test the hypothesis that melatonin could attenuate myocardial injury in a rat CPB model. METHODS: Eighteen male Sprague-Dawley rats were randomly divided into three groups, n = 6 for each group: the sham operation (SO) group, CPB group and melatonin group. Rats in the SO group underwent cannulation without CPB, rats in CPB group intraperitoneal injected an equal volume of vehicle daily for 7 days before being subjected to CPB and rats in melatonin group intraperitoneal injected 20 mg/kg of melatonin solution daily for 7 days before being subjected to CPB. After 120 min for CPB, the expression levels of plasma interleukin (IL) -6, IL-1β, superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), malondialdehyde (MDA), creatine kinase (CK) -MB and cardiac troponin T (cTnT) were measured. Reactive oxygen species (ROS) were detected by dihydroethidium (DHE). Apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining. Mitochondrial damage and autophagosomes were detected by electron microscopy. Apoptosis inducing factor (AIF) was detected by immunofluorescence. The expression of B cell lymphoma/leukemia2 associated X (Bax), B cell lymphoma/leukemia 2 (Bcl-2), cytochrome C (Cyto-C), cleaved caspase-9, AKT, p-AKT, signal transducer and activator of transcription 3 (STAT3), p-STAT3, LC3, P62, mechanistic target of rapamycin kinase (mTOR), p-mTOR and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were determined using western blotting. RESULTS: Melatonin significantly decreased the levels of IL-1β, IL-6, MDA, CK-MB and cTnT and increased the levels of SOD and GSH-Px, all of which were altered by CPB. Melatonin reduced cardiomyocyte superoxide production, the apoptosis index and autophagy in cardiomyocytes induced by CPB. The AKT, STAT3 and mTOR signaling pathways were activated by melatonin during CPB. CONCLUSION: Melatonin may serve as a cardioprotective factor in CPB by inhibiting oxidative damage, apoptosis and autophagy. The AKT, STAT3 and mTOR signaling pathways were involved in this process.
format Online
Article
Text
id pubmed-8053380
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-80533802021-05-04 Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model Huang, Xiaolin Hou, Jian Huang, Suiqing Feng, Kangni Yue, Yuan Li, Huayang Huang, Shaojie Liang, Mengya Chen, Guangxian Wu, Zhongkai PeerJ Biochemistry BACKGROUND: Myocardial injury is a frequent complication after cardiac surgery with cardiopulmonary bypass (CPB). This study aimed to test the hypothesis that melatonin could attenuate myocardial injury in a rat CPB model. METHODS: Eighteen male Sprague-Dawley rats were randomly divided into three groups, n = 6 for each group: the sham operation (SO) group, CPB group and melatonin group. Rats in the SO group underwent cannulation without CPB, rats in CPB group intraperitoneal injected an equal volume of vehicle daily for 7 days before being subjected to CPB and rats in melatonin group intraperitoneal injected 20 mg/kg of melatonin solution daily for 7 days before being subjected to CPB. After 120 min for CPB, the expression levels of plasma interleukin (IL) -6, IL-1β, superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), malondialdehyde (MDA), creatine kinase (CK) -MB and cardiac troponin T (cTnT) were measured. Reactive oxygen species (ROS) were detected by dihydroethidium (DHE). Apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining. Mitochondrial damage and autophagosomes were detected by electron microscopy. Apoptosis inducing factor (AIF) was detected by immunofluorescence. The expression of B cell lymphoma/leukemia2 associated X (Bax), B cell lymphoma/leukemia 2 (Bcl-2), cytochrome C (Cyto-C), cleaved caspase-9, AKT, p-AKT, signal transducer and activator of transcription 3 (STAT3), p-STAT3, LC3, P62, mechanistic target of rapamycin kinase (mTOR), p-mTOR and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were determined using western blotting. RESULTS: Melatonin significantly decreased the levels of IL-1β, IL-6, MDA, CK-MB and cTnT and increased the levels of SOD and GSH-Px, all of which were altered by CPB. Melatonin reduced cardiomyocyte superoxide production, the apoptosis index and autophagy in cardiomyocytes induced by CPB. The AKT, STAT3 and mTOR signaling pathways were activated by melatonin during CPB. CONCLUSION: Melatonin may serve as a cardioprotective factor in CPB by inhibiting oxidative damage, apoptosis and autophagy. The AKT, STAT3 and mTOR signaling pathways were involved in this process. PeerJ Inc. 2021-04-15 /pmc/articles/PMC8053380/ /pubmed/33954056 http://dx.doi.org/10.7717/peerj.11264 Text en ©2021 Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Biochemistry
Huang, Xiaolin
Hou, Jian
Huang, Suiqing
Feng, Kangni
Yue, Yuan
Li, Huayang
Huang, Shaojie
Liang, Mengya
Chen, Guangxian
Wu, Zhongkai
Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model
title Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model
title_full Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model
title_fullStr Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model
title_full_unstemmed Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model
title_short Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model
title_sort melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model
topic Biochemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053380/
https://www.ncbi.nlm.nih.gov/pubmed/33954056
http://dx.doi.org/10.7717/peerj.11264
work_keys_str_mv AT huangxiaolin melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel
AT houjian melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel
AT huangsuiqing melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel
AT fengkangni melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel
AT yueyuan melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel
AT lihuayang melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel
AT huangshaojie melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel
AT liangmengya melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel
AT chenguangxian melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel
AT wuzhongkai melatoninamelioratesmyocardialinjurybyreducingapoptosisandautophagyofcardiomyocytesinaratcardiopulmonarybypassmodel